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Abstract. Alzheimer’s Disease (AD) is referred to as one of the most common
causes of dementia, which in itself justiﬁes the interest and investment that is
made in order to ﬁnd new biomarkers to identify the disease in its early stages.
Indeed, focusing on the hippocampus as a marker for AD, it would be object of
analyse different methods of volume measurement and hippocampus segmen-
tation. On the other hand, the computational framework is built on top of a
Logic Programming approach to Knowledge Representation and Reasoning,
complemented with a computational framework base on Artiﬁcial Neural Net-
works that grip on incomplete, unknown, and even self-contradictory informa-
tion or knowledge.
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1 Introduction
Alzheimer’s Disease (AD) is the most common cause of dementia in the world,
affecting 20% of the population over 80 years, and being estimated as the cause of 60 to
80% of the death cases. This disease is characterized by initial alterations in the
neuroﬁbrillary tangles and the deposit of amyloid- b plaque. Later this evolves to
variations at the level of the brain structure, causing atrophy [1–3].
In the ﬁeld of medical imaging, initially images of CT Computed Tomography
(CT) and Magnetic Resonance Imaging (MRI) where used to distinguish between AD
and other types of dementia. However, medical imaging as assume a more central role
in the detection of the disease, with the ﬁnding of new biomarkers, not only for
detection and follow up of AD, but also to others types of dementia. The uncertainty of
the diagnosis of AD, lead to this search of biomarkers that could identify the disease in
its early stages, and because a deﬁnitive diagnosis requires conﬁrmation, through
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